ResMed Enters Accelerated Share Repurchase Agreement To Repurchase $450 Million Of Common Stock - RMD News | RalliesResMed Enters Accelerated Share Repurchase Agreement To Repurchase $450 Million Of Common Stock
R
RMD• ResMed announces $450 million share repurchase
- ResMed Inc. said it has entered into an accelerated share repurchase agreement to repurchase $450 million of common stock.
- The company said it will fund the share repurchase with proceeds from the sale of MatrixCare and cash on hand.
- Final settlement of the ASR agreement is scheduled for December 2026.
•
